Obesity drugmaker Novo Nordisk raises outlook
- Country:
- United Kingdom
Novo Nordisk raised its 2024 outlook on Thursday as the Danish drugmaker races to boost output of its hugely popular weight-loss drug Wegovy and fend off competition from Eli Lilly.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
ALSO READ
Behold the Arrival of the BMW M4 Competition M xDrive in India
Health News Roundup: Bird flu likely circulated in US cows for four months before diagnosis -paper; Novo Nordisk trims price for blockbuster obesity drug as competition heats up and more
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
London's black cab drivers sue Uber for unfair competition
National Federation Cup Athletics Competition Kicks Off
Google News